Production (Stage)
Assembly Biosciences, Inc.
ASMB
$13.52
-$0.04-0.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.15M | 28.52M | 28.33M | 21.48M | 12.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.15M | 28.52M | 28.33M | 21.48M | 12.95M |
| Cost of Revenue | 58.91M | 55.93M | 52.66M | 49.97M | 46.23M |
| Gross Profit | -26.75M | -27.41M | -24.33M | -28.49M | -33.28M |
| SG&A Expenses | 17.88M | 18.01M | 22.11M | 22.04M | 22.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.79M | 73.94M | 74.77M | 72.01M | 68.76M |
| Operating Income | -44.63M | -45.42M | -46.44M | -50.53M | -55.82M |
| Income Before Tax | -39.59M | -39.85M | -40.37M | -45.17M | -51.32M |
| Income Tax Expenses | 330.00K | 330.00K | 439.00K | 439.00K | 33.00K |
| Earnings from Continuing Operations | -39.92 | -40.18 | -40.80 | -45.61 | -51.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.92M | -40.18M | -40.80M | -45.61M | -51.36M |
| EBIT | -44.63M | -45.42M | -46.44M | -50.53M | -55.82M |
| EBITDA | -44.50M | -45.29M | -46.26M | -50.27M | -55.46M |
| EPS Basic | -6.25 | -6.73 | -7.21 | -8.98 | -10.89 |
| Normalized Basic EPS | -3.87 | -4.17 | -4.45 | -5.57 | -6.80 |
| EPS Diluted | -6.25 | -6.73 | -7.21 | -8.98 | -10.89 |
| Normalized Diluted EPS | -3.87 | -4.17 | -4.45 | -5.57 | -6.80 |
| Average Basic Shares Outstanding | 26.04M | 24.01M | 22.80M | 20.83M | 19.54M |
| Average Diluted Shares Outstanding | 26.04M | 24.01M | 22.80M | 20.83M | 19.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |